文献速递瓣膜病与结构性心脏病

主动脉瓣周围脂肪组织CT衰减与主动脉瓣狭窄无关联

Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis.
PubMed 文献 · Heart · 2024-04-15

本研究在120例主动脉瓣狭窄(AS)患者和80例对照中测量主动脉瓣周围脂肪组织的CT衰减值,评估其与AS疾病严重程度、活动性和进展的关系。结果显示该衰减值在AS与对照间无差异,与AS严重程度、活动性及进展均无关联,提示其无临床价值。

要点

  • 主动脉瓣周围脂肪组织CT衰减在AS与对照组间无显著差异。
  • 该衰减值与AS严重程度、活动性及进展均无关联。
  • 提示其不能作为AS评估和管理的生物标志物。

核心结论

  • CT测量的主动脉瓣周围脂肪组织衰减与AS疾病严重程度、活动性或进展无关,无临床价值。

研究设计与样本

  • 研究纳入AS患者120例和对照80例,测量主动脉瓣周围径向3mm、纵向10mm的脂肪组织CT衰减值。

主要发现

  • AS患者与对照的衰减值分别为-62.4(-68.7,-56.5)HU和-61.2(-65.3,-55.6)HU,p=0.099。
  • 轻度、中度和重度AS患者的衰减值分别为-60.2(-66.9,-55.1)HU、-62.8(-69.6,-56.80)HU和-62.3(-69.3,-55.4)HU,组间比较均p>0.05。
  • 衰减值与超声心动图或CT钙化评分的AS严重程度无关联,与18F-氟化钠PET评估的疾病活动性也无关联。
  • 基线衰减值与后续AS进展(峰值流速年化变化)无关联,r=0.072,p=0.458。
  • 使用其他五种图像分析方法得到相似结果。

临床怎么用

  • 不建议将主动脉瓣周围脂肪组织CT衰减用于AS患者的评估和管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aortic stenosis (AS) shares pathophysiological similarities with atherosclerosis including active inflammation. CT attenuation of perivascular adipose tissue provides a measure of vascular inflammation that is linked to prognosis and has the potential to be applied to the aortic valve. We investigated perivascular adipose tissue attenuation around the aortic valve in patients with AS. METHODS: CT attenuation was measured in the perivascular adipose tissue extending 3 mm radially and 10 mm longitudinally around the aortic valve in patients with and without AS. Associations between perivascular adipose tissue attenuation and AS disease severity, activity and progression were investigated. RESULTS: Perivascular adipose tissue attenuation around the aortic valve demonstrated good intraobserver and interobserver repeatability (interobserver: intraclass correlation coefficient 0.977 (95% CI: 0.94, 0.99)) but was similar between patients with AS (n=120) and control subjects (n=80) (-62.4 (-68.7, -56.5) Hounsfield units (HU) vs -61.2 (-65.3, -55.6) HU, p=0.099). There were no differences between perivascular adipose tissue attenuation in patients with mild (-60.2 (-66.9, -55.1) HU), moderate (-62.8 (-69.6, -56.80) HU) or severe (-62.3 (-69.3, -55.4) HU) AS (all p>0.05), and perivascular adipose tissue attenuation did not demonstrate an association with AS severity as assessed by echocardiography or CT calcium scoring, nor with disease activity assessed by 18F-sodium fluoride positron emission tomography. Moreover, there was no association between baseline aortic valve perivascular adipose tissue attenuation and subsequent AS progression (annualised change in peak velocity: r=0.072, p=0.458). Similar results were found using five other image analysis methods. CONCLUSIONS: CT-derived aortic valve perivascular adipose tissue attenuation is not associated with AS disease severity, activity or progression suggesting that it has no value in the investigation and management of patients with AS.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Botezatu SB, Yu X, Meah MN, et al. Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis. Heart. 2024. PMID: 37918901. doi:10.1136/heartjnl-2023-323217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。